Medical equipment industry
On February 10, 2004, StockPickReport.Com, a registered investment advisor, released its short-term stock recommendations. The firm provides unbiased technical analysis for its clients, offering a unique perspective on potential price movements over the next five to ten trading sessions. Key Takeaways: * StockPickReport.Com recommends selling Medtronic Inc (NYSE:MDT)
Medical equipment industry
The Money Gang, a popular segment on CNNfn, provides expert analysis and insights on the stock market and key players in the industry. The show features a team of experts, including Liz Miller, Trevor Stewart Burton, and Jacobsen, who share their opinions and advice on various stocks and market trends.
Medical equipment industry
According to a recent report by StockPickReport.Com, four major companies have received short-term stock recommendations. Citigroup (NYSE:C) and Atmel Corp (Nasdaq:ATML) have been rated as SELL stocks. Honeywell International (NYSE:HON) has also been rated as a SELL stock. In contrast, Schlumberger Ltd (NYSE:SLB) has been
Medical equipment industry
Medtronic has launched the Medtronic Paceart System, 2004 First Edition, to help clinics with heart rhythm disorders electronically organize cardiac device and patient heart rate data. This new release significantly improves data accessibility by providing a seamless interface between Paceart and various healthcare information systems (HIS). The export module utilizes
Medical equipment industry
StockPickReport.Com, a stock research firm, has made short-term stock recommendations for six companies, including Nextel Communications, Broadcom Corp, FleetBoston Financial Cp, Medtronic Inc, International Game Technology, and other notable players. These ratings are based on the company's proprietary unbiased system of technical analysis, which reflects the potential
Medical equipment industry
MacroPore Biosurgery Inc, a San Diego-based company, has completed a 12-month clinical evaluation of its new faster resorbing polymer (FRP) bioresorbable implant system. The product, cleared by the US Food and Drug Administration (FDA) for craniofacial and neurosurgical applications, has shown comparable safety and efficacy to the company's
Medical equipment industry
Angiotech Pharmaceuticals, Inc. and its corporate partner, Cook Incorporated, were set to merge with Guidant Corporation. However, due to Guidant's announcement that conditions for the merger are "not expected to be satisfied," the deal has been put on hold. Guidant cited the entry of a final
Medical equipment industry
Guidant Corp, a specialist in cardiac and vascular diseases, is making an equity investment in Spiration Inc, a US-based company that develops medical devices for treating lung disease. Spiration's products, including an intra-bronchial valve and the VALR surgical system, have shown promise in early pre-clinical trials for treating
Medical equipment industry
Pursuers of McKesson HBOC, Inc.'s common stock between January 12, 1999 and April 27, 1999, as well as former stockholders of US Servis, IMNET Systems, Inc., and Access Health, Inc. who exchanged their shares for the company's inflated stock, are being represented in a lawsuit filed
Medical equipment industry
A shareholder sued McKesson HBOC, Inc. for allegedly issuing materially false and misleading financial statements after the company's acquisition of HBO & Company in January 1999. The lawsuit, which seeks class action status, claims that HBO & Company and McKesson HBOC made false statements between April 14, 1998,
Pharmaceutical industry
OPTISON, a state-of-the-art cardiac ultrasound contrast imaging agent, has made a significant impact on the medical community with its groundbreaking technology. Developed by Molecular Biosystems and marketed by Mallinckrodt, OPTISON has been the subject of over a dozen presentations at the 1999 annual meeting of the American College of Cardiology
Pharmaceutical industry
Pharmacia & Upjohn, a global pharmaceutical and healthcare company, and Centocor, a leading biopharmaceutical company, have announced an agreement to co-promote FRAGMIN (dalteparin sodium injection) in the United States. The agreement aims to strengthen Pharmacia & Upjohn's FRAGMIN business in the US and enhance Centocor's leadership
